Continuous subcutaneous infusion of pramlintide and insulin: a randomized, crossover design study

Trial Profile

Continuous subcutaneous infusion of pramlintide and insulin: a randomized, crossover design study

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2009

At a glance

  • Drugs Pramlintide (Primary) ; Insulin
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Jul 2008 Actual completion date (November 2007) added as reported by ClinicalTrials.gov.
    • 17 Jul 2008 Actual patient number added (13) as reported by ClinicalTrials.gov.
    • 17 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top